[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555765":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":10,"centralContacts":26,"locations":36,"responsibleParty":64,"collaborators":67,"id":75,"slug":76,"hasResults":77,"nctId":78,"briefTitle":79,"officialTitle":79,"acronym":10,"eligibilityCriteria":80,"healthyVolunteers":77,"sex":81,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":10,"studyType":87,"phases":10,"briefSummary":88,"conditions":89,"keywords":92,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"IRCCS Ospedale San Raffaele","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"UC patients",null,"Patients with histologically confirmed UC undergoing intestinal resection due to stricturing disease. These patients will be divided into two groups:\n\npatients with (case group) and without (control group) postoperative recurrence",[13],"Procedure: UC patients",{"label":15,"type":10,"description":16,"interventionNames":17},"CD patients","Patients with histologically confirmed CD undergoing intestinal resection due to stricturing disease. Divided into two groups: patients with (case group) and without (control group) postoperative recurrence",[18],"Procedure: CD patients",[20,24],{"type":21,"name":15,"description":22,"armGroupLabels":23,"otherNames":10},"PROCEDURE","The study will involve the collection of leftover surgical material after pathologist analysis, mucosal brushes, an additional volume of blood and feces of patients at the time of surgery",[15],{"type":21,"name":9,"description":22,"armGroupLabels":25,"otherNames":10},[9],[27,32],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Pierpaolo Sileri, MD. PhD.","CONTACT","+39 0226436275","sileri.pierpaolo@hsr.it",{"name":33,"role":29,"phone":34,"phoneExt":10,"email":35},"Federica Ungaro, PhD.","+39 0226437864","ungaro.federica@hsr.it",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":40,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Milan","Italy","20132","IT",{"type":44,"coordinates":45},"Point",[46,47],9.18951,45.46427,{"lat":47,"lon":46},[50,52,53,55,58,60,62],{"name":51,"role":29,"phone":30,"phoneExt":10,"email":31},"Pierpaolo Sileri, MD, PhD.",{"name":33,"role":29,"phone":34,"phoneExt":10,"email":35},{"name":51,"role":54,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"name":56,"role":57,"phone":10,"phoneExt":10,"email":10},"Federica Ungaro, PhD","SUB_INVESTIGATOR",{"name":59,"role":57,"phone":10,"phoneExt":10,"email":10},"Andrea Vignali, MD",{"name":61,"role":57,"phone":10,"phoneExt":10,"email":10},"Luca Albarello, MD",{"name":63,"role":57,"phone":10,"phoneExt":10,"email":10},"Alice Frontali, MD",{"type":54,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Pierpaolo Sileri","Professor",[68,71,73],{"name":69,"class":70},"IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo","UNKNOWN",{"name":72,"class":6},"Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona",{"name":74,"class":6},"Ministero della Salute, Italy","100555765","spatially-and-temporally-resolving-predictive-biomarkers-of-postoperative-recurrence-and-complications-in-chronic-intestinal-inflammation-100555765",false,"NCT06516341","Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation","Inclusion Criteria:\n\n* adult (age \\>18 years) patients with histologically confirmed CD or UC undergoing intestinal resection due to stricturing disease, regardless of their current or past medical treatment;\n* given that it is an observational study, also pregnant and breastfeeding patients could be included;\n* able and willing to sign the informed consent.\n\nExclusion Criteria:\n\n* patients \\\u003C18 years or \\> 70 years;\n* patients with unconfirmed both UC and CD diagnoses;\n* patients with superimposed dysplasia or cancer diagnosis and resections for which post- operative endoscopic assessment of recurrence is not feasible;\n* patients unable or unwilling to sign the informed consent.","ALL","18 Years","69 Years",{"count":85,"type":86},35,"ESTIMATED","OBSERVATIONAL","A portion of patients with Inflammatory bowel disease often require surgical intervention since they do not respond to the current therapies. Besides this risk, patients may develop post-operative disease complications, and the factors beneath are far from being understood or predicted. The investigators hypothesize that some priming factors remain in the resection margin after surgery and act as a memory of the evolution of the disease, leading to the recurrence or complications. The following proposals are made:\n\n1. defining and validating in humanized experimental models of intestinal inflammation the spatial and temporal dynamics of the postoperative complications-priming factors\n2. integrating them into a machine-learning-driven model to determine risk indices of disease recurrence in IBD patients. This risk prediction model will not change the clinical decision-making process but will only be built for research. Consequently, patients enrolled in this study will be monitored and treated as per the standard of care.\n\nThis project will reveal possible causes and build methods predictive of postoperative complications ultimately resulting in changes in clinical management in the near future.",[90,91],"Ulcerative Colitis","Crohn Disease",[90,91,93,94,95,96,97],"Stenosis","Post-operative recurrence","IBD","Biomarker prediction","Stricturing disease","2025-03-11",{"date":100,"type":101},"2025-03-14","ACTUAL",{"date":103,"type":101},"2025-02-27",{"date":105,"type":86},"2026-09",{"name":5,"class":6},1]